
Enzamide 40 mg contains enzalutamide, a nonsteroidal androgen receptor inhibitor prescribed primarily for castration-resistant prostate cancer (CRPC)—both metastatic (spread beyond the prostate) and non-metastatic forms.
| Generic Name | Enzalutamide |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 56 Capsules |
| Prescribed For | Prostate Cancer |
| Availability | In Stock |




As a trusted provider of high-quality oncology medicines, we offer authentic Enzamide (Enzalutamide 40mg) Capsules, commonly prescribed for the treatment of advanced prostate cancer.
We guarantee safe, timely, and consistent bulk supply of generic prostate cancer drugs, including Enzalutamide (Xtandi), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.